90 Brain Fitness Patents for Posit Science
Rate of Invention in Applied Brain Science Continues to Accelerate
SAN FRANCISCO, June 23 /PRNewswire/ -- Posit Science, the leading provider of brain fitness software, today announced that it was issued patent number 7,540,615 by the US Patent & Trademark Office. Posit Science now owns ...
Misonix Announces the Purchase of Patents From ProRhythm, Inc.
FARMINGDALE, N.Y., June 12 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON ), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that it has purchased th...
Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)
SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced the licensing of certain intellectual property (IP) from GlaxoSmithKline (GSK) that expands the Company's IP position unde...
Impliant Granted Two New U.S. Patents and Successfully Defends European Patent Opposition Case
PRINCETON, N.J., June 9 /PRNewswire/ -- Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that the European Patent Office has confirmed the validity of one of its key patents
following an Opposition by Archus Orthopedics, Inc. (Redmond, WA) tha...
CAP Joins Landmark Lawsuit Challenging Legality of Myriad Genetics Gene Patents
The College of American Pathologists today joined a lawsuit against the U.S. Patent and Trademark Office and Myriad Genetics, challenging the legality of Myriad's patents
for the genes known as BRCA1 and BRCA2, which are indicators for hereditary predisposition to breast and ovarian cancer.
ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics
BETHESDA, Md., May 12 /PRNewswire-USNewswire/ -- The American College of Medical Genetics (ACMG) has joined the Association for Molecular Pathology, the College of American Pathologists, and the American Society for Clinical Pathology in a lawsuit filed today charging that patents
on the human gen...
ACLU Challenges Patents on Breast Cancer Genes
Stifle Patient Access To Medical Care And Critical Research
NEW YORK, May 12 /PRNewswire-USNewswire/ -- The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents
on two human genes...
German Federal Patent Court Invalidates Wake Forest NPWT Patents Licensed to KCI
ST. PETERSBURG, Fla., March 17 /PRNewswire-FirstCall/ -- Smith & Nephew Inc.'s Advanced Wound Management division (LSE: SN; NYSE: SNN ) announced that the German Federal Patent Court in Munich has held the Wake Forest patent for negative pressure (NPWT) licensed to Kinetic Concepts, Inc. (...
Aribex(R) Awarded Patents for Handheld X-ray
OREM, Utah, Jan. 19 /PRNewswire/ -- Aribex, Inc., a world leader in handheld x-ray technologies, announced today that it has been allowed a second U.S. patent for its NOMAD Handheld X-ray System.
The latest patent (Appl. # 20070269010) protects the central concept of having all components of...
U.S. Patent and Trademark Office Issues Mylan's Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution
PITTSBURGH, Jan. 12 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL )
today announced that its subsidiary Dey L.P. has been issued several
additional U.S. patents
protecting the company's Perforomist(R) Inhalation
Solution, a chronic obstructive pulmonary disease (COPD) treatment.
Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications
NEW YORK, Jan. 7 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. ( OTC Bulletin Board: ILNS ), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), announced today that it has granted a non-...
Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimer's Patents and Patent Applications
Agreement Follows Recent Grant by Intellect of License to Wyeth (NYSE:
WYE) and Elan Pharma International Ltd.
NEW YORK, Oct. 8 /PRNewswire-FirstCall/ -- Intellect Neurosciences,
Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on
development of disease-modifying therapeu...
U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
MIAMI, Sept. 15 /PRNewswire/ -- The U.S. District Court in Delaware
today granted Cordis Corporation's motion for final judgment against Boston
Scientific Corporation and Medtronic, Inc. in their cases involving the
original Palmaz balloon expandable stent patent.
Cordis had asked U.S. Distr...
TruFUSE(R) Patents Awarded
CLEARWATER, Fla., July 8 /PRNewswire/ -- minSURG(TM) Corporation,
through its parent company, Orthopedic Development Corporation, has
received a Notice of Allowance from the United States Patent and Trademark
Office on two of its pending US patent applications. The patents
the designs ...
Telik Announces Patents on Compounds Related to TELINTRA
PALO ALTO, Calif., June 10 /PRNewswire-FirstCall/ -- Telik, Inc.
(Nasdaq: TELK ), announced today that the European Patent Office has issued
notices of allowance for two applications covering new compounds related to
one of Telik's lead clinical candidates, TELINTRA(R). Corresponding
Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products
Glycoproducts International Inc., found to have committed patent and trademark infringement
COPPELL, Texas, May 12 /PRNewswire-FirstCall/ -- Mannatech,
Incorporated (Nasdaq: MTEX ) a leading developer and provider of dietary
supplements and skin care solutions, today...
MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents
COMPANY ALSO ANTICIPATES MYMEDICALRECORDS PHR TO OFFER CCHIT MANDATED FEATURES
LOS ANGELES, April 20 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: FVRL), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides c...
United States Patent Office Rejects KCI's Patents
ST. PETERSBURG, Fla., Feb. 19 /PRNewswire-FirstCall/ -- Smith & Nephew's Advanced Wound Management division (LSE: SN; NYSE: SNN ) announced that the United States Patent and Trademark Office (Patent Office) has rejected as unpatentable three of KCI's negative pressure wound therapy (NPWT) pa...
ALSIUS CORPORATION PREPARED TO INVALIDATE ZOLL TEMPERATURE MANAGEMENT PATENTS
IRVINE, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS ), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced that it is prepared to respond aggressively to the patent lawsuit brought against it...
U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents
ST. PETERSBURG, Fla., Feb. 2 /PRNewswire-FirstCall/ -- Smith & Nephew's Advanced Wound Management division (LSE: SN; NYSE: SNN ) today announced that the U.S. Court of Appeals for the Federal Circuit upheld a trial court judgment that the gauze-based Versatile 1 negative pressure wound the...
MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents
GERMANTOWN, Md., Nov. 6 /PRNewswire-FirstCall/ -- MiddleBrook
Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical company focused on
developing and commercializing novel anti-infective products, today
announced that three patents
protecting Moxatag (amoxicillin
extended-release) Tablets, ...
Court Rejects Two Medtronic Patents
Boston Scientific obligation reduced from $250 to $19 million
NATICK, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Boston Scientific
Corporation (NYSE: BSX ) today announced that the U.S. District Court of
Marshall, Texas found two patents
of Medtronic, Inc. (NYSE: MDT )
unenforceable for i...
The Quantum Group Files Four Additional Patents
Company Expands IP Portfolio to Nine Filings, with Additional Applications Expected
WELLINGTON, Fla., April 17 /PRNewswire-FirstCall/ -- The Quantum Group,
Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com ) announced today that
it has filed four addit...
Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
ROCKVILLE, Md., April 15 /PRNewswire-FirstCall/ -- Neuralstem, Inc.
(Amex: CUR ) today responds to an earlier press release by StemCells, Inc.
by stating that StemCells, Inc. has completely mischaracterized the meaning
of the US Patent and Trademark Office's most recent action.
Cyberonics Licenses Obesity-Related Patents
HOUSTON, Dec. 18 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:
CYBX) announced that effective December 18, 2007, the company has entered
into an agreement with Ethicon Endo-Surgery granting exclusive rights to
the company's patents
and patent applications pertaining to vagus nerve
Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
Announced for Methods of Cloning Livestock From
Differentiated Donor Cells
AUSTIN, Texas, Dec. 11 /PRNewswire-USNewswire/ -- Start Licensing, Inc.
(Start) announced today that the U.S. Patent and Trademark Office has
granted U.S. Patent Nos. 7,304,204 and 7,307,198 covering met...
US Denies Granting Patents on Yoga Postures
Amid a raging row in India over reported attempts to patent the ancient Indian practice of yoga overseas, the US denied granting patents
on yoga positions.
In the same breath, the US embassy said here that it has granted patents
on "new and non-obvious devices that may be used in conjunction...
Dr Reddy’s Laboratories to challenge patents on drug
Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents
on drugs in the US despite the recent denial of a 180-day marketing exclusivity to its generic Omeprazole 40 mg capsules by the US Food and Drug Administration. Omeprazole is indicated for the treatment of duodenal...
People Before Patents
The Médecins Sans Frontière (MSF), a leading organization of conscientious and concerned doctors, has issued an alert about a lawsuit that the Swiss drugs firm//, Novartis, has brought against India, demanding a patent for one of its products (Gleevac, a leukemia drug).
Critics say that drug f...
Thailand Backs Off Threat to Break Drug Patents
Thailand has delayed breaking the patent of an AIDS drug and a heart medicine, and entered into negotiations with drug firms// to lower the price so that more people can be treated.
The negotiation panel of the Public Health Ministry yesterday (7 February) held its first talks with US firm Abbo...
Labopharm Reports Results for Second Quarter Fiscal 2009
...ted to sales and marketing and the accrual for the Company's share of litigation costs incurred by Purdue Pharma to enforce certain of Purdue's U.S. patents
related to Labopharm's once-daily tramadol product. These were partially offset by lower costs for consultants and professional services, a reduction ...
NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
...re businesses. "
NutraCea is a world leader in production and utilization of stabilized rice bran. NutraCea holds many patents
for stabilized rice bran production technology and proprietary neutraceutical formulas ranging from arthritis, chronic bowel conditions, and effective...
Transcept Pharmaceuticals to Report Second Quarter 2009 Results
The FDA has established October 30, 2009 as its target date under PDUFA to take action on its review of the NDA. Transcept is actively pursuing patents
to protect Intermezzo (R) in the United States and key non-U.S. markets, and, as part of the NDA submission, has requested that the FDA grant three y...
Winner Medical Schedules 2008/2009 Third Quarter Earnings Release on Tuesday, August 11, 2009
cotton. The products are sold world-wide, with Europe, the US and Japan
serving as the top three markets. The Company currently holds 50 patents
patent applications in various products and manufacturing processes and is one
of the few Chinese companies licensed with the US Food and Drug Adm...
The Reduction of Eye Fatigue Improves Vision in Older Subjects
...reas of astaxanthin research that Fuji is actively supporting include cardiovascular, diabetes and metabolic syndrome. Fuji Chemical also holds seven patents
for astaxanthin in human application as well as numerous pending patents. Fuji's AstaReal brand of astaxanthin is approved for use in nutritional supp...
ICBS to focus on pharmaceutical and environmental markets
...tions in the detection of Total Coliforms and E.coli to WHO standards using globally approved methods (USEPA, AWWA-APHA). The company holds world wide patents
NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements ar...
Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
...e competitive with its products. In addition, while Amgen routinely obtain patents
for its products and technology, the protection offered by its patents
and patent applications may be challenged, invalidated or circumvented by i...
AccuVein Vein Illuminator Receives European CE Mark
...ice miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents
filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.
For more information...
Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth Conference
...bbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents
worldwide. Additional information about Isis is available at www.isispharm.com .
DURECT Corporation Announces Second Quarter 2009 Financial
... ORADUR(R) technology, which is covered by issued patents
patent applications owned by us...he referenced product candidates, avoid infringing patents
held by other parties and secure and defend patents
of our own, and manage and obtain capital to fund ...